Prognostic staging of extensively pretreated patients with advanced HIV-1 disease.

Montaner, Julio; Guimaraes, Denise; Chung, Jain; Gafoor, Zarina; Salgo, Miklos; DeMasi, Ralph

Montaner, Julio; Guimaraes, Denise; Chung, Jain; Gafoor, Zarina; Salgo, Miklos; DeMasi, Ralph.

Affiliation

Montaner J; St. Paul's Hospital, University of British Columbia, Vancouver, Canada. jmontaner@cfenet.ubc.ca

HIV Clin Trials ; 6(6): 281-90, 2005.

Article in En | MEDLINE | ID: mdl-16566082

Subject(s)

HIV Envelope Protein gp41/therapeutic use; HIV Fusion Inhibitors/therapeutic use; HIV Infections/drug therapy; HIV-1/physiology; Peptide Fragments/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Enfuvirtide; Female; HIV Infections/blood; HIV Infections/immunology; HIV Infections/virology; Humans; Logistic Models; Male; Middle Aged; Prognosis; RNA, Viral/blood; Viral Load; Virus Replication/drug effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp41 / HIV Infections / HIV-1 / HIV Fusion Inhibitors Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links